Drugs / benzoyl-L-tyrosyl-[1-13C]alanine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01259544 Comparator | Jan → Feb 2009 | chronic pancreatitis | Meridian Bioscience, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | benzoyl-L-tyrosyl-[1-13C]alanine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01259544 ↗ |
| Known as | Bz-Tyr-Ala | “benzoyl-L-tyrosyl-[1-13C]alanine (Bz-Tyr-Ala)” NCT01259544 ↗ |
| Modality | Peptide | “13C labeled di-peptide” NCT01259544 ↗ |